There are many positive outcomes for OHS patients being treated with NIV:
- Improved blood gases during the night, which in turn improves them during the day
- Relieved ventilatory muscles1
- Positive effect on lung function, especially when residual capacity is increased2
- Lower mortality compared to OHS patients not treated with NIV.3
- OHS patients require a high level of medical care, and are more likely to be hospitalised. (8.6 times higher than for general population control subjects)3
- OHS patients have been found to make 11.2 physician visits per year compared to 5.7 visits for obese-only patients. 3
- Effective treatment of OHS has shown a significant reduction in physician fees and a 68.4% decrease in annual hospitalisation days. 3
Contal O, Carnevale C, Borel JC, Sabil A, Tamisier R, Levy P, Janssens JP, Pepin JL. Pulse transit tima as a measure of respiratory effort under nonivasive ventilation. Eur Respir J. 2013 41(2):346-53
Budweiser, S., Hitzl A.P., Jörres, R.A., Schmidbauer, K., Heinemann, F., Pfeifer, M., (2007). Health-related quality of life and long-term prognosis in chronic hypercapnic respiratory failure: a prospective survival analysis. Respir Res 8(17): 92
OHS is defined as chronic daytime hypercapnia in obese patients after ruling out any other ...
It’s important to recognise OHS in your patients and get them treated.
Recommended treatment options for OHS include controlled weight loss and non-invasive ventilation.
Adhering to therapy is critical for patients receiving non-invasive ventilation.